BRCA1 mutations are almost exclusively associated with female breast and ovarian cancer, whereas BRCA2 families are also at risk for male breast cancer, pancreatic cancer in both males and females, and prostate cancers [95]. This evidence concerns the gene BRCA1 and ovarian cancer.